ClinicalTrials.gg
Active, not recruitingNCT04660526Updated Oct 28, 2026

RACE-CARS - RAndomized Cluster Evaluation of Cardiac ARrest Systems

An interventional study of Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators and Systematic bystander resuscitation instruction by 911 operators in Cardiac Arrest, sponsored by Duke University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Duke University · Not applicable, Interventional, and Health services research

How we know

Updated Oct 28, 2026Study documents postedPrimary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20,000
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 171 studies in Heart Arrest with a site in United States — 40 open to participants now, 45 under way, 2 of them phase 3. Heart Arrest · United States.

Planned enrollment
5th of 117
20,000 · median 72
Started
2022
with 4 others
No phase
67 of 171
15 open now
Primary completion
2026-09
later than 3 of 44 live
Registered
114th of 171
by date

Among the 171 studies in Heart Arrest with a site in United States, this one is the 5th largest by planned enrollment of the 117 interventional ones that give a count, is one of 5 that started in 2022, is one of 67 with no phase, reaches primary completion later than 3 of the 44 other live ones, and was the 114th registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

40 of the 171 studies in Heart Arrest with a site in United States are open now. Recruiting first, the newest first:

35 more — sign in →

All 40 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 171 studies in Heart Arrest with a site in United States, or all of them as a file.
02

Study summary

RACE-CARS is a real-world cluster-randomized trial designed to evaluate a multifaceted community and health systems intervention aimed to improve outcomes of out-of-hospital cardiac arrest. RACE-CARS will enroll 50 counties in North Carolina that are estimated to have a total of approximately 20,000 patients with cardiac arrest over a 4-year intervention period. County "clusters" will be randomized in a 1:1 ratio to intervention versus usual care. The trial duration is 7 years, which includes a 6-month start-up (including recruitment and randomization) period, a 12-month intervention training phase, a 4-year intervention period, a 12-month follow-up for to assess quality of life in survivors of OHCA, and a 6-month close-out and data analysis period.

03

Conditions studied

  • Cardiac Arrest

Keywords

  • cardiac arrest
  • cardiopulmonary resuscitation
  • telephone CPR
  • dispatch CPR
  • out-of-hospital cardiac arrest
  • defibrillation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • OHCA of non-traumatic etiology
  • Patients who are pulseless on arrival of a first responder; or patients who become pulseless in the presence of a first responder; OR patients who have a pulse on arrival of EMS, where a successful defibrillation was previously administered by a bystander or first responder.

Exclusion criteria

Exclusion Criteria:

  • Untreated cardiac arrests, including arrests in which resuscitation efforts are not initiated or are terminated immediately upon arrival of EMS because the patient is not a viable candidate for resuscitation due to:

    1. injuries incompatible with life,
    2. the presence of rigor mortis or lividity,
    3. signs of decomposition, or
    4. the presence of a valid DNR.
  • Private EMS transport that did not involve 911 dispatch (example: interfacility transport between nursing home and hospital).
  • Arrest of clear and obvious traumatic etiology
  • Bystander suspected cardiac arrest, where ROSC was achieved without the need for defibrillation or first responder CPR
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20,000 participants (estimated)

Study arms

  • Experimental
    Intervention (Enhanced Standard of Care)

    Mass community CPR/AED training, optimize 911 medical dispatch, improve first responder performance

    Other: Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators · Other: Systematic bystander resuscitation instruction by 911 operators · Other: Comprehensive community training of lay people in CPR and AED use. · Other: Optimized first responder performance including earlier use of AEDs.

  • No intervention
    Control (Standard of Care)

    Usual care, continuing standard quality improvement effort

Interventions

  • OtherRapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators

    EMS first responders will recognize cardiac arrest and respond immediately, increasing time to dispatch

  • OtherSystematic bystander resuscitation instruction by 911 operators

    911 operators will be able to describe how to administer CPR over the phone.

  • OtherComprehensive community training of lay people in CPR and AED use.

    Training of lay people regarding CPR and AED use.

  • OtherOptimized first responder performance including earlier use of AEDs.

    First responders will recognize where AEDs are located and use them appropriately

06

What researchers measure

Primary outcomes

  1. Survival with good neurologic outcomes as measured by a CPC score of 1 or 2 at discharge

    Cerebral Performance Category (CPC)

    Time frame: up to 12months

Secondary outcomes

  1. Percent of patients who receive CPR from a bystander as measured by EMS report

    Time frame: Baseline

  2. Rate of Defibrillation before paramedics arrive as measured by bystander interview

    Time frame: Baseline

Other outcomes

  1. Percent of cardiac arrest patients whose cardiac arrests are recognized by 911-dispatcher through telephone call

    Time frame: Baseline

  2. Percent of cardiac arrest patients with responders who receive CPR instructions by 911-dispatcher through telephone call

    Time frame: Baseline

  3. Survival rate as measured by medical record abstraction

    Time frame: Follow-up, up to 12 months

  4. Change in Neurologic disability as measured by Modified Rankin Score

    The Modified Rankin Score is a 6 point likert scale, with 0 being "No symptoms" and 6 being "Dead"

    Time frame: 3 months, 12 months

  5. Change in Quality of life as measured by the SF-36

    The SF-36 is Is a health-related quality-of-life questionnaire consisting of thirty six questions that measure eight health domains to assess physical and mental health. Physical health-related domains include General Health (GH), Physical Functioning (PF), Role Physical (RP), and Body Pain (BP).

    Time frame: 3 months, 12 months

  6. Change in Quality of life as measured by the EQ-5D-5L

    The EQ-5D-5L is Quality of Life instrument measure with one question for each of the five dimensions that include mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.

    Time frame: 3 months, 12 months

07

Study locations

1 site
08

References and documents

Publications

  • Krychtiuk KA, Starks MA, Al-Khalidi HR, Mark DB, Monk L, Yow E, Kaltenbach L, Jollis JG, Al-Khatib SM, Bosworth HB, Ward K, Brady S, Tyson C, Vandeventer S, Baloch K, Oakes M, Blewer AL, Lewinski AA, Hansen CM, Sharpe E, Rea TD, Nelson RD, Sasson C, McNally B, Granger CB; RACE-CARS NC Counties. RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and design. Am Heart J. 2024 Nov;277:125-137. doi: 10.1016/j.ahj.2024.07.013. Epub 2024 Jul 30. PubMed 39084483 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2022 to primary completion in Sep 2026, 50 months.

Of 205 non-industry interventional studies with no phase under Heart Arrest, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 47. This study's 50 months is above that.

Counting every sponsor, half of 219 studies reached it within 28 months; a quarter within 10 and three quarters within 48.

Primary completion moved once since we started tracking on Sep 25, 2026: Aug 2026 → Sep 2026, on Oct 28, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2020
First posted
Dec 9, 2020
StartActual
Jul 1, 2022
Primary completionActual
Sep 30, 2026was Aug 2026
CompletionEst.
Jun 30, 2027
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Aug 31, 2026→Sep 30, 2026 (actual)
Oct 28, 2026
Documents
Oct 28, 2026
Secondary outcomes
3 time frame changed
What changed in the outcomes
  • Time frameother outcomePercent of cardiac arrest patients whose cardiac arrests are recognized by 911-dispatcher through telephone callFollow-up, up to 4 years → Baseline
  • Time frameother outcomePercent of cardiac arrest patients with responders who receive CPR instructions by 911-dispatcher through telephone callFollow-up, up to 4 years → Baseline
  • Time frameother outcomeSurvival rate as measured by medical record abstractionFollow-up, up to 4 years → Follow-up, up to 12 months
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    Documents Informed consent form ↗ posted
    Primary completion Aug 31, 2026→Sep 30, 2026 (now actual)
    Secondary outcomes 3 time frame changed
    What changed in the outcomes
    • Time frameother outcomePercent of cardiac arrest patients whose cardiac arrests are recognized by 911-dispatcher through telephone callFollow-up, up to 4 years → Baseline
    • Time frameother outcomePercent of cardiac arrest patients with responders who receive CPR instructions by 911-dispatcher through telephone callFollow-up, up to 4 years → Baseline
    • Time frameother outcomeSurvival rate as measured by medical record abstractionFollow-up, up to 4 years → Follow-up, up to 12 months

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04660526
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Dec 9, 2020
Start date
Jul 1, 2022
Primary completion
Sep 30, 2026
Completion
Jun 30, 2027 (estimated)
Last update
Oct 28, 2026

Study contacts

Christopher Granger, MD
principal investigator · Duke University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion